T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
2376
DELISTED
Cymabay Therapeutics
CBAY
| $502K | ﹤0.01% |
137,574
| – | – |
|
2377
PetMed Express
PETS
$43.4M
| $497K | ﹤0.01% |
18,496
+315
| +2% | +$9.07K |
|
|
IMGN
2378
DELISTED
Immunogen Inc
IMGN
| $497K | ﹤0.01% |
87,688
+786
| +0.9% | +$4.54K |
|
2379
The Joint Corp
JYNT
$119M
| $496K | ﹤0.01% |
+5,057
| New | +$473K |
|
2380
Hayward Holdings
HAYW
$3.24B
| $495K | ﹤0.01% |
+22,248
| New | +$500K |
|
|
AAT
2381
American Assets Trust
AAT
$1.41B
| $494K | ﹤0.01% |
13,207
-16
| -0.1% | -$607 |
|
|
GOOD
2382
Gladstone Commercial Corp
GOOD
$641M
| $493K | ﹤0.01% |
23,440
-114
| -0.5% | -$2.56K |
|
|
DHC
2383
Diversified Healthcare Trust
DHC
$2.03B
| $492K | ﹤0.01% |
144,987
+433
| +0.3% | +$1.63K |
|
2384
OneSpan
OSPN
$624M
| $491K | ﹤0.01% |
26,150
| – | – |
|
|
CNSL
2385
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $490K | ﹤0.01% |
53,271
-13,035
| -20% | -$116K |
|
|
WSR
2386
DELISTED
Whitestone REIT
WSR
| $489K | ﹤0.01% |
49,993
+896
| +2% | +$8.21K |
|
2387
GrowGeneration
GRWG
$108M
| $487K | ﹤0.01% |
19,734
-3,900
| -17% | -$138K |
|
2388
Motorcar Parts of America
MPAA
$235M
| $487K | ﹤0.01% |
24,990
+160
| +0.6% | +$3.35K |
|
2389
AudioCodes
AUDC
$253M
| $484K | ﹤0.01% |
14,869
| – | – |
|
|
EPZM
2390
DELISTED
Epizyme, Inc
EPZM
| $482K | ﹤0.01% |
94,158
-160,208
| -63% | -$973K |
|
2391
Li Auto
LI
$12B
| $481K | ﹤0.01% |
+18,300
| New | +$550K |
|
|
CNR
2392
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $476K | ﹤0.01% |
32,588
-4,300
| -12% | -$69.9K |
|
2393
The Greenbrier Companies
GBX
$1.42B
| $472K | ﹤0.01% |
10,984
-56
| -0.5% | -$2.41K |
|
|
TRTX
2394
TPG RE Finance Trust
TRTX
$616M
| $471K | ﹤0.01% |
38,069
-3,700
| -9% | -$47.4K |
|
2395
Nice
NICE
$6.17B
| $469K | ﹤0.01% |
1,650
+74
| +5% | +$20.5K |
|
2396
Construction Partners
ROAD
$6.73B
| $468K | ﹤0.01% |
14,026
| – | – |
|
2397
Stewart Information Services
STC
$2.07B
| $465K | ﹤0.01% |
7,343
| – | – |
|
|
TBI
2398
Trueblue
TBI
$309M
| $465K | ﹤0.01% |
17,176
+126
| +0.7% | +$3.37K |
|
2399
Lemonade
LMND
$4.1B
| $464K | ﹤0.01% |
6,926
+898
| +15% | +$72.4K |
|
|
BRSP
2400
BrightSpire Capital
BRSP
$629M
| $462K | ﹤0.01% |
49,184
+6,200
| +14% | +$59.9K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.